New U.S. bird-flu case is first with respiratory symptoms, CDC says
BioNTech and CEPI Expand Partnership to Strengthen Africa's mRNA Vaccine Ecosystem
BioNTech gains antibody drug conjugate platform license from Chinese biotech
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
Reiterating Buy on BioNTech Amid Strategic Growth and Upcoming Catalysts
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
Buy Rating Affirmed for BioNTech SE on Strong Pipeline and Strategic Expansion
Buy Rating on BioNTech SE Amidst Undervaluation and Strong Pipeline Prospects
Moderna, BioNTech close with double-digit percentage gains amid bird flu fears
Human Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Moderna, CureVac, other vaccine stocks jump after new human bird-flu case reported in Australia
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
Temasek Backs OpenAI Investor’s New $250 Million Tech Fund
Moderna vaccine patent upheld by European Patent Office: report
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.